Malvinder Mohan Singh is an Indian businessmen with the Fortis health care , Ranbaxy and Religare business. Singh attended The Doon School, Dehradun and graduated in Economics from St. Stephens College, Delhi. He also received an MBA from Duke University's Fuqua School of Business. He is a former chairman and CEO of Ranbaxy Laboratories, an Indian unit of Japanese drugmaker Daiichi Sankyo, who resigned in 2009 after Ranbaxy posted losses and after Daiichi Sankyo decided to get more actively involved in the newly acquired Indian unit.Mr. Malvinder Singh serves as the Managing Director of Agro Dutch Industries Limited. Mr. Singh served as Managing Director of Vishwa Calibre Bjftfers pvt. Ltd. Mr. Singh has 26 years of business experience. He has been an Executive Chairman of Saptarishi Agro Industries Limited since August 4, 2014.
Malvinder Singh is part owner of Fortis Healthcare and Religare Wellness
RANBAXY LABSRanbaxy Laboratories Limited (BSE: 500359) is an Indian multinational pharmaceutical company that was incorporated in India in 1961. The company went public in 1973 and Japanese pharmaceutical company Daiichi Sankyo acquired a controlling share in 2008. In 2014, Ranbaxy was ranked 184th among India's most trusted brands according to the Brand Trust Report 2014, a study conducted by Trust Research Advisory, a brand analytics company.
Ranbaxy was started by Ranbir Singh and Gurbax Singh in 1937 as a distributor for a Japanese company Shionogi. The name Ranbaxy is a portmanteau of the names of its first owners Ranbir and Gurbax. Bhai Mohan Singh bought the company in 1952 from his cousins Ranbir and Gurbax. After Bhai Mohan Singh's son Parvinder Singh joined the company in 1967, the company saw an increase in scale.